Weekend Prince capsules recalled for lack of FDA approval
R Thomas Marketing, LLC is recalling Weekend Prince capsules because they were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The source text explicitly identifies the agency classification as Class I, which mandates a severity score of 5 according to the rubric.
Plain-English summary
R Thomas Marketing, LLC is recalling Weekend Prince, a product packaged in 24 individual cards containing 2 capsules per card (48 capsules total). The product was distributed nationwide via Internet sales. All lots are affected by this recall.
The recall is being conducted because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). This means the product has not been evaluated by the FDA for safety, efficacy, or quality.
Consumers who have purchased Weekend Prince should stop using the product and contact the distributor for further instructions. The FDA classifies this recall as Class I, indicating a reasonable probability that use of the product may cause serious adverse health consequences or death.
The recalled product
- Product
- Weekend Prince, packaged in 24 individual cards / 2 capsules per card/ 48 capsules total, Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467
- Manufacturer
- R Thomas Marketing, LLC
- Category
- Drug — Unapproved Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 24 recalled by R Thomas Marketing, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 24 products in this recall →Related recalls
Same manufacturer · R Thomas Marketing, LLC
See all →- SevereMan King capsules recalled for lack of FDA approval
FDA (Drugs) · 2016-06-01
- SevereFDA Recalls Black Storm Capsules Marketed Without Approval
FDA (Drugs) · 2016-06-01
- SevereFDA Recalls Zhen Gong Fu for Lack of Approved New Drug Application
FDA (Drugs) · 2016-06-01
- SevereBull's Genital Recalled for Marketing Without FDA Approval
FDA (Drugs) · 2016-06-01
- SeverePlant Vigra Recalled for Lack of FDA Approval
FDA (Drugs) · 2016-06-01
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04
Similar recalls
- SevereMiss Slim capsules recalled for unapproved marketing distribution
FDA (Drugs) · 2021-09-01
- CriticalHard Times For Men capsules recalled for undeclared sildenafil
FDA (Drugs) · 2018-01-31
- CriticalSuper Panther 7K Capsules Recalled for Unapproved Ingredients
FDA (Drugs) · 2017-09-20
- SevereAndropharm Sten Z capsules recalled for lack of FDA approval
FDA (Drugs) · 2017-09-20
- CriticalGadget Island Recalls Unapproved Rhino 7 Platinum 5000 Capsules
FDA (Drugs) · 2017-12-13
- CriticalFDA Recalls 7K Capsules Containing Undeclared Sildenafil and Tadalafil
FDA (Drugs) · 2018-06-06